astrazeneca a brief overview pre-pharmacy society meeting university of delaware rocco r. duran...
Post on 18-Dec-2015
215 views
TRANSCRIPT
![Page 1: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/1.jpg)
AstraZenecaA brief overview
Pre-Pharmacy Society MeetingUniversity of DelawareRocco R. Duran R.Ph.Senior QA Executive – Global Quality Operations
![Page 2: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/2.jpg)
2
Everyone cares about healthYoung or old. Rich or poor. Around the world. It’s one thingthat we all have in common
AstraZeneca is here to makea difference to people’s health
![Page 3: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/3.jpg)
3
Doctors and patients
70 years of innovative medicines Touching the lives of many people
People who pay for healthcare
Our shareholders
The wider community
Our employees
![Page 4: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/4.jpg)
4
Our focus is on six areas of medicine
Cancer
Cardiovascular disease
Infection
Gastrointestinal disease
Neurological disorders
Respiratory & inflammatory conditions
![Page 5: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/5.jpg)
Top 8%Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success. We are positioned in the top 8% in the sector in the Dow Jones World and STOXX (European) Sustainability Indexes.
We employ over 61,000 people 47% in Europe, 30% in the Americas, 23% in Asia, Africa and Australasia
We invest over $4 billion in R&D each year and have over 15,500 people in our R&D organisation
In 2010, our worldwide sales totalled $33.3 billion).
![Page 6: AstraZeneca A brief overview Pre-Pharmacy Society Meeting University of Delaware Rocco R. Duran R.Ph. Senior QA Executive – Global Quality Operations](https://reader036.vdocuments.site/reader036/viewer/2022062714/56649d255503460f949fbeb2/html5/thumbnails/6.jpg)
|Pre-Pharmacy Society Meeting – November 10, 20116
Thank you for your time and interest
For more information about AstraZeneca and activities worldwide, visit astrazeneca.com